Fundraising Fox
Protenus
AcquiredBaltimore, US · Founded 2014 · Delaware corporation · 222 employees on LinkedIn · 9 known investors
Find your way into Protenus
Sign up to see every warm intro you have to Protenus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Protenus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bluesight (formerly Protenus) provides AI-powered software for hospital pharmacy and compliance teams, covering RFID inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring. It integrates data from wholesalers, health records, dispensing cabinets, and HR systems to support pharmacy operations and executive analytics for health systems.
Founders & leadership
Protenus was founded in 2014 by Nicholas Culbertson.
NC
Nicholas CulbertsonFounder
HT
Harry TotonisNamed on SEC filing
MK
Michele KangNamed on SEC filing
Board
RL
Investors · 9
Arthur Ventureslisted by Arthur VenturesMinneapolis · $1M – $10M
How we know: Arthur Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
F-Prime Capitallisted by F-Prime CapitalCambridge · $3M – $10M
How we know: F-Prime Capital's portfolio page · a partner's Signal profile · Not right? Tell us
__Twitter.png)
Kaiser Permanente Ventureslisted by Kaiser Permanente VenturesSan Francisco · $2M – $5M
How we know: Kaiser Permanente Ventures's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
LionBirdlisted by LionBirdTel Aviv · $200K – $500Kvia Robert Lord · board
How we know: LionBird's portfolio page · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
MemorialCare Innovation Fundlisted by MemorialCare Innovation FundLong Beach
How we know: MemorialCare Innovation Fund's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$47.7M disclosed across 8 rounds · 2014–2021
▶$15.7MraisedMay 2021 · 9 investors · Other TechnologyRule 506(b)
▶$15.7MraisedMay 2021 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sam BraschDirector
- Robert LordDirector
- Nicholas CulbertsonExecutive Officer, Director
- Jon LimDirector
- James BurgumDirector
- Offering amount
- $20M
- Amount sold
- $15.7M
- Minimum investment
- $100K
- Proceeds to insiders
- $1M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13MraisedMay 2019 · 9 investors · Other TechnologyRule 506(b)
▶$13MraisedMay 2019 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas CulbertsonExecutive Officer, Director
- Jared KesselheimDirector
- James BraschDirector
- James BurgumDirector
- Jon LimDirector
- Jon OtterstatterDirector
- Robert LordExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $13M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$11MraisedJan 2018 · 8 investors · Other TechnologyRule 506(b)
▶$11MraisedJan 2018 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas CulbertsonExecutive Officer, Director
- Robert LordExecutive Officer, Director
- Sam BraschDirector
- Jon LimDirector
- Edward MichaelDirector
- Offering amount
- $11M
- Amount sold
- $11M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$7MraisedJul 2017 · 21 investors · Other TechnologyRule 506(b)
▶$7MraisedJul 2017 · 21 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas CulbertsonExecutive Officer, Director
- Robert LordExecutive Officer, Director
- Edward MichaelDirector
- Michele KangDirector
- John SteinerDirector
- Offering amount
- $7M
- Amount sold
- $7M
- Proceeds to insiders
- $175K
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$150KraisedMar 2015 · 2 investors · Other TechnologyRule 506(b)
▶$150KraisedMar 2015 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Robert LordExecutive Officer, Director
- Nicholas CulbertsonExecutive Officer, Director
- Harry TotonisDirector
- Michele KangDirector
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$770KraisedSep 2014 · 10 investors · Other TechnologyRule 506(b)
▶$770KraisedSep 2014 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas CulbertsonExecutive Officer, Director
- Robert LordExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $770K
- Minimum investment
- $10K
- Proceeds to insiders
- $120K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$30KraisedMay 2014 · 1 investors · Other TechnologyRule 506(b)
▶$30KraisedMay 2014 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Robert LordDirector
- Nicholas CulbertsonDirector
- Offering amount
- $30K
- Amount sold
- $30K
- Proceeds to insiders
- $12K
- First sale
- Apr 2014
- Incorporated
- Limited Liability Company, Maryland, 2014
- Federal exemptions
- 06b
▶$50KraisedMay 2014 · 3 investors · Other TechnologyRule 506(b)
▶$50KraisedMay 2014 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Robert LordDirector
- Nicholas CulbertsonDirector
- Offering amount
- $50K
- Amount sold
- $50K
- Proceeds to insiders
- $12K
- First sale
- Apr 2014
- Incorporated
- Limited Liability Company, Maryland, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Bswiftbswift provides an AI-native benefits administration platform paired with expert service and an in-house engagement agency, helping HR teams manage enrollment, employee communications, and benefits engagement. It serves employers across industries, including large organizations, and offers tools such as an AI benefits assistant and personalization engine to increase benefits utilization and contain healthcare costs.
PerkvillePerkville provides a branded loyalty and referral software platform that enables businesses to drive customer engagement through points-based rewards, referral programs, promotional campaigns, and tiered membership structures.
F-Prime CapitalBeam Therapeutics develops CRISPR base editing technology to create precision genetic medicines for treating human diseases. The company focuses on therapeutic applications using single-letter DNA modifications.
Companies working in the same space as Protenus.
Frequently asked questions
- What does Protenus do?
- Bluesight (formerly Protenus) provides AI-powered software for hospital pharmacy and compliance teams, covering RFID inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring. It integrates data from wholesalers, health records, dispensing cabinets, and HR systems to support pharmacy operations and executive analytics for health systems.
- Who founded Protenus?
- Protenus was founded by Nicholas Culbertson in 2014.
- Who are Protenus's investors?
- Protenus's investors include Arthur Ventures, F-Prime Capital, Gaingels, Kaiser Permanente Ventures, Kube VC, LionBird, MemorialCare Innovation Fund, TCP Venture Capital and 1 more.
- How much funding has Protenus raised?
- Protenus has disclosed $47.7M raised across 8 rounds.
- Where is Protenus headquartered?
- Protenus is headquartered in Baltimore, US.